InvestWiserOssDsign AB
OSSD · Nasdaq Stockholm · Healthcare
3.54SEK
−1.3%last day
Price as of 2 October 2026
Performance
1 month
−4.2%
1 year
−75.5%
3 years, per year
−16.5%
5 years, per year
−16.0%
Largest fall, 3 years
−79.3%
Below the peak now
−81.2%
Volatility, 1 year
70.2%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
1.3
Dividend yield
0.0%
Return on equity
−17.7%
Net margin
−31.1%
Market value
39 m USD
Quality, value and trend
Where OssDsign stands against every Nordic stock today. 100 is best.
76
Profitability and a sound balance sheet over time. Better than 76% of Nordic stocks.
35
The price measured against earnings, assets and cash flow. Better than 35% of Nordic stocks.
6
The price development over the past year. Better than 6% of Nordic stocks.
28
Quality, value and trend together. Better than 28% of Nordic stocks.
About OssDsign
OssDsign AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 41 employees.
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis